FDA is reviewing preliminary data from a recent study suggesting
that patients using sibutramine have a higher number of
cardiovascular events (heart attack, stroke, resuscitated cardiac
arrest, or death) than patients using a placebo.
Electrical Engineering News and Products
Electronics Engineering Resources, Articles, Forums, Tear Down Videos and Technical Electronics How-To's